A phase II study of toripalimab combined with gemcitabine-cisplatin as neoadjuvant therapy for patients with muscle-invasive bladder cancer (MIBC)

被引：0
|
作者：
Xu, Abai
Xu, Peng
Chen, Chunxiao
Liu, Zhe
Jiang, Ning
Bi, Enguang
Cao, Manming
Chen, BinShen
Liu, Chunxiao
机构：
[1] Southern Med Univ, Zhujiang Hosp, Dept Urol, Guangzhou, Peoples R China
[2] Southern Med Univ, Zhujiang Hosp, Dept Oncol, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16602
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II clinical trial of toripalimab combined with cisplatin plus gemcitabine chemotherapy as neoadjuvant treatment for muscle-invasive bladder cancer
    Yang, Rong
    Li, Tianhang
    Zhang, Shun
    Zhang, Shiwei
    Guo, Hongqian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Phase II trial of neoadjuvant gemcitabine (G) and cisplatin (C) with sunitinib in patients (pts) with muscle-invasive bladder cancer (MIBC)
    Balar, Arjun Vasant
    Iyer, Gopa
    Apolo, Andrea Borghese
    Regazzi, Ashley Marie
    Garcia-Grossman, Ilana Rebecca
    Pendse, Deepa
    Ostrovnaya, Irina
    Chou, Joanne F.
    Bochner, Bernard
    Dalbagni, Guido
    Herr, Harry W.
    Milowsky, Matthew I.
    Bajorin, Dean F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Neoadjuvant sintilimab combined with gemcitabine and cisplatin (GP) for muscle-invasive bladder cancer (MIBC) patients followed by selective bladder sparing surgery
    Tong, Z.
    Fu, G.
    Zhou, F.
    Liu, X.
    Xue, X.
    Zhang, H.
    Wang, Y.
    Zhu, X.
    Gao, Y.
    Liu, L.
    Bao, X.
    Zheng, Y.
    Fang, W.
    Zhao, P.
    Jin, B.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1210 - S1210
  • [4] Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer
    Narayan, Vivek
    Mamtani, Ronac
    Keefe, Stephen
    Guzzo, Thomas
    Malkowicz, S. Bruce
    Vaughn, David J.
    [J]. CANCER RESEARCH AND TREATMENT, 2016, 48 (03): : 1084 - 1091
  • [5] Phase II study of gemcitabine and split-dose cisplatin plus pembrolizumab as neoadjuvant therapy prior to radical cystectomy (RC) in patients with muscle-invasive bladder cancer (MIBC).
    Rose, Tracy L.
    Harrison, Michael Roger
    Deal, Allison Mary
    Osterman, Chelsea K.
    Ramalingam, Sundhar
    Whang, Young E.
    Brower, Blaine Y.
    Bjurlin, Marc
    Smith, Angela B.
    Nielsen, Matthew E.
    Tan, Hung-Jui
    Wallen, Eric M.
    George, Daniel J.
    Zhang, Tian
    Drier, Anthony
    Kim, William Y.
    Milowsky, Matthew, I
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [6] Neoadjuvant gemcitabine-cisplatin (GC) for muscle-invasive bladder cancer (MIBC): Does midway CT staging predict for pathologic complete response (pCR)?
    Seah, Jo-An
    Leibowitz-Amit, Raya
    Atenafu, Eshetu G.
    Alimohamed, Nimira
    Joshua, Anthony Michael
    Knox, Jennifer J.
    Tannock, Ian
    Sridhar, Srikala S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [7] Neoadjuvant Gemcitabine Plus Cisplatin for Muscle-invasive Bladder Cancer
    Kaneko, Gou
    Kikuchi, Eiji
    Matsumoto, Kazuhiro
    Obata, Jun
    Nakamura, So
    Miyajima, Akira
    Oya, Mototsugu
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (07) : 908 - 914
  • [8] Neoadjuvant nivolumab, gemcitabine and cisplatin in muscle-invasive bladder cancer: Study update
    Gupta, Shilpa
    Weight, Christopher J.
    Agarwal, Neeraj
    Gupta, Sumati
    Konety, Badrinath
    Gibb, Ewan
    Davicioni, Elai
    Thyagarajan, Bharat
    Sonpavde, Guru
    [J]. CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [9] Camrelizumab in combination with gemcitabine plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer
    Xing, N.
    Han, S.
    Jiang, J.
    Xu, W.
    Shi, B.
    Ping, H.
    Ji, Z.
    Ma, Q.
    Wang, H.
    Chen, S.
    Wang, W.
    Fan, X.
    Zhou, Q.
    Zhang, W.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S714 - S714
  • [10] Is neoadjuvant chemotherapy with gemcitabine plus cisplatin beneficial in patients with muscle-invasive bladder cancer?
    Yafi, Faysal A.
    Kassouf, Wassim
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 747 - 752
12345